CellCarta

Global contract research organization (CRO) providing specialty laboratory services to support the entire drug development cycle.

[CellCarta @CellCarta]

At #CYTO2026, make sure to catch Xavier Dagenais-Lussier, Senior Scientist to learn how CellCarta scientists are accelerating assay design for clinical trials.

Book a meeting to learn more: 👩‍🔬👨‍🔬 https://t.co/zxlDWSaV9C

[CellCarta @CellCarta]

We caught a few CellCarta team members at the #ASCO2026 sign!

We're thrilled to be in Chicago discussing how we can accelerate your oncology programs.

Haven't caught the team? We're always available to discuss your programs- send us a message 📩 https://t.co/YZc1bpCvpU

[CellCarta @CellCarta]

Press Release: CellCarta and Leica Biosystems are expanding their proven companion diagnostic (CDx) framework for flexible, end-to-end CDx development to biopharma sponsors worldwide.

Read the full announcement: https://t.co/hcDdFGTPAE

[CellCarta @CellCarta]

CellCarta is attending #CYTO2026! We'll be showing off CellEngine, our fast and flexible software for flow cytometry analysis, at Booth 606!

Plus, visit our poster on accelerating spectral flow assay development for clinical trials. Reach out: https://t.co/3iDJXRkCIN

[CellCarta @CellCarta]

Big news: CellCarta and Sonic Healthcare USA are partnering to bridge companion diagnostic development and commercial deployment, as Sonic Healthcare USA joins CellCarta's Lab Network, supporting our single-site PMA CDx bridging strategy.

Learn more: https://t.co/GWPxYe0mYa

[CellCarta @CellCarta]

Join us at ASCO!

We support oncology programs in generating reliable, regulatory-ready data with integrated multi-omic capabilities, supported by comprehensive sample management and logistics solutions.

Book a meeting with our team: https://t.co/The3xD3wXi

#ASCO2026

[CellCarta @CellCarta]

The quality and rigor of your early-stage programs determines the success of your therapeutic development. Our California laboratory helps teams generate insights quickly and confidently.

Get the insights your early-stage program needs, fast: https://t.co/OwmLYGvOcS

[CellCarta @CellCarta]

Don't miss the 3rd annual CellCarta Connect Challenge event in Shanghai, on May 20th. This scientific symposium brings together leading scientists and clinicians at the intersection of oncology, biomarkers, and diagnostics.

Register today 👉https://t.co/cHHHO7oSKP

[CellCarta @CellCarta]

We are proud to announce the 2025 recipient of the Bob Fritzen Memorial Award, created in memory of our colleague as a tribute to his commitment to our core values: Trust & Respect, Passion & Perseverance, and Customer Excellence. Through this, we continue to honor Bob’s impact.

[CellCarta @CellCarta]

When a biotech sponsor needed two brand-new multiplex immunofluorescence assays developed, validated, and clinically tested against a hard conference deadline, our California laboratory team delivered, ahead of schedule.

Read the full case study here: https://t.co/U4wqpISCTh

[CellCarta @CellCarta]

The CellCarta team is heading to Chicago for ASCO! If you'll be there, make sure to book a meeting with the team to learn how we can support your programs from early stages to CDx development.

Book a meeting with the team here: https://t.co/6055UbGVp3

[CellCarta @CellCarta]

🤝 CellCarta and Leica Biosystems China have partnered to help make CDx development in China faster and more coordinated.

Learn more about the partnership: https://t.co/g4NX983eim

[CellCarta @CellCarta]

Don't miss the 3rd annual CellCarta Connect Challenge event in Shanghai , on May 20th. This scientific symposium brings together leading scientists and clinicians at the intersection of oncology, biomarkers, and diagnostics.

Register today 👉https://t.co/1mpsbNJI0n

[CellCarta @CellCarta]

Our team had a great time at TRI-CON! We presented our innovative CDx bridge model, designed to help biopharma teams accelerate companion diagnostic development with faster, more cost-effective strategies.

Interested? Connect with our team 👉 https://t.co/hY8OEZBQfs

[CellCarta @CellCarta]

Innovation that anticipates your needs. From routine assays to complex studies, our immunologists are trusted by start-ups and large pharma to get the data you need.

👨‍🔬👩‍🔬Get started: https://t.co/38UX7BDz45

[CellCarta @CellCarta]

Last week, CellCarta celebrated Medical Laboratory Week!

During lab week we honor the incredible contributions of our lab professionals, who play a critical role in advancing patient https://t.co/yhBiF4ZAtr’s to you, our lab heroes!

#LabWeek2026 #PrecisionMedecine

[CellCarta @CellCarta]

Attending TRI-CON? Don't miss the introduction of our innovative hybrid model designed to deliver speed and flexibility in precision medicine CDx.

Interested in learning more? Reach out to our team to see how we can support your CDx development. https://t.co/hY8OEZBQfs

[CellCarta @CellCarta]

The #ADC field is expanding fast, and so is the list of biomarkers driving it.
That's where our California laboratory comes in, actively expanding our IHC and spatial biology assay portfolio to keep pace with the evolving ADC landscape. Learn more: https://t.co/8JGyki3Let

[CellCarta @CellCarta]

Think you’ve got what it takes to top the leaderboard? 🎮
Swing by Booth #4647 and prove it! Ready, set, game on! 💥

#AACR2026

[CellCarta @CellCarta]

When it comes to flow cytometry data analysis software, we know what matters: making it fast and easy to use.

Whether you have a few tubes, dozens of 384-well plates, or multi-gigabyte FCS files, CellEngine is ready to make analysis easier. Try it today! https://t.co/kqWDVCy2jY